Ultima Tren A 100 Ultima Pharmaceuticals: Compound Profile
Ultima Tren A 100 is a trenbolone acetate injection formulated for in-vitro steroid research applications. Trenbolone acetate represents one of the most potent synthetic anabolic steroids in research settings, derived from 19-nortestosterone with modifications at the C-19 and C-11 positions. This pharmaceutical-grade research compound from Ultima Pharmaceuticals enables detailed investigation into androgenic receptor binding mechanisms and anabolic pathway modulation. Researchers at Stroid UK Shop utilise this compound to examine advanced steroid chemistry and receptor selectivity studies.
Laboratory Applications
Scientific investigations with Ultima Tren A 100 focus on trenbolone acetate’s unique molecular structure and its interactions with androgen receptor complexes. The acetate ester provides rapid compound release characteristics, making it valuable for time-sensitive research protocols examining acute anabolic effects. Laboratory studies investigate trenbolone’s five-fold greater binding affinity compared to testosterone, alongside its resistance to aromatisation and 5α-reductase metabolism. Research applications span steroid biochemistry, receptor pharmacology, and comparative anabolic mechanism studies. Investigators examining steroid injections frequently select trenbolone acetate for its distinct pharmacokinetic profile and potent research characteristics.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Trenbolone Acetate |
| Concentration | 100mg/mL |
| Manufacturer | Ultima Pharmaceuticals |
| Molecular Formula | C₂₀H₂₄O₃ |
| CAS Number | 10161-34-9 |
| Storage | Room temperature, protect from light |
Advanced researchers also investigate complementary compounds including SARMs and peptides to understand comparative anabolic mechanisms and receptor selectivity profiles.
Research Compliance
Ultima Tren A 100 is manufactured exclusively for in-vitro research purposes and laboratory analysis. This product is not intended for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory protocols and comply with institutional guidelines for controlled substance research. All investigations should be conducted by qualified personnel in approved research facilities with proper safety equipment and waste disposal procedures.
